Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of the Rheumatic Diseases (ARD)
A first joint EULAR/PReS guideline unifies systemic juvenile idiopathic arthritis and adult-onset Still’s disease under a single name, Still’s disease, and recommends early IL-1 or IL-6 inhibitor therapy over prolonged glucocorticoid use.
Pediatric Hematology/Oncology June 30th 2026
Vaccine Advisor
The FDA has approved the first generic version of baloxavir marboxil, a single-dose influenza antiviral noninferior to oseltamivir, ahead of the 2026-2027 flu season.
Family Medicine/General Practice June 30th 2026
Clinical Advisor
Past-year creatine use among U.S. adolescents roughly doubled between 2019 and 2024, even as anabolic steroid use continued a two-decade decline, according to a national survey of nearly 875,000 students.
Adolescent Medicine June 30th 2026
MDLinx
A resurgent social media challenge involving high-dose diphenhydramine ingestion has been linked to seizures, cardiac arrest, and adolescent deaths, with poison center calls more than doubling in the first half of 2026 compared with all of 2025.
The Journal of Clinical Endocrinology & Metabolism (JCEM)
A new Endocrine Society guideline favors watchful waiting over immediate evaluation for many girls with early breast development, narrows brain MRI and genetic testing to select cases, and sets age limits for stopping GnRH agonist therapy.
News Medical
Single-nucleus multi-omics sequencing across genetically diverse ASD mouse models revealed convergent molecular and cellular changes in early brain development, despite distinct underlying mutations.
Neurology June 30th 2026